Ziyad Al-Aly, MD Profile picture
Feb 22 19 tweets 6 min read Read on X
📣 New in @ScienceMagazine

I teamed up with @EricTopol to write this #SciencePerspective on Long Covid

Solving the puzzle of #LongCovid

A long 🧵

science.org/doi/10.1126/sc…
First, what is Long Covid?

It is a complex nonmonolithic multisystemic disease with sequelae across almost all organ systems

It can manifest across the life span (from children to older adults) and across race & ethnicity, sex, & baseline health status

science.org/doi/10.1126/sc…
Long Covid is likely a disease with many subtypes that may have different risk factors (genetic, environmental, etc.) and distinct biologic mechanisms that may respond differently to treatments.

science.org/doi/10.1126/sc…
More than 90% of cases occur in people who had mild SARS-CoV-2 infection

science.org/doi/10.1126/sc…
Mechanisms of Long Covid include viral persistence, dysregulated immune response, mitochondrial dysfunction, vascular (endothelial) and/or neuronal inflammation and microbiome dysbiosis

science.org/doi/10.1126/sc…
COVID-19 vaccines, COVID-19 antivirals and metformin reduce the risk of Long Covid

science.org/doi/10.1126/sc…
Reinfection contributes additional risks of Long Covid

it can trigger de novo Long Covid or exacerbate its severity.

Efforts to prevent reinfection are critical to reduce the risk of long-term population health loss

science.org/doi/10.1126/sc…
We highlight some challenges

a. Care needs of people with Long Covid must be met

science.org/doi/10.1126/sc…
b. The attribution of #LongCovid symptoms to psychological causes has no scientific support; it perpetuates stigma and disenfranchises patients from accessing the care they need.

This belongs in the dustbin of history.

science.org/doi/10.1126/sc…
c. The lack of consensus on terms, definitions, and clinical trial end points for Long Covid is slowing progress and hampering industry engagement in clinical trials.

Building consensus on these parameters is urgently needed.

science.org/doi/10.1126/sc…
Historical accounts of the Spanish flu of 1918, EBV, poliomyelitis & others taught us that acute infections can have consequences decades later

This highlights the need for studies to identify latent effects of COIVD-19 that may not have materialized

science.org/doi/10.1126/sc…
Registered trials for Long Covid are too small and underpowered to yield conclusive evidence;

they are being conducted at a slow pace that is unlikely to yield answers to inform patient care for years, if not decades.

science.org/doi/10.1126/sc…
Looking ahead:

We must urgently find treatments!!!!

Trials for Long Covid MUST match the scale and urgency of the problem.

science.org/doi/10.1126/sc…
Preventing infections and reinfections is the best way to prevent Long Covid and should remain the foundation of public health policy.

science.org/doi/10.1126/sc…
This includes

➡️masking — especially in high risk places
➡️improved air quality through filtration and ventilation
➡️Updating building codes to require mitigation against airborne pathogens

science.org/doi/10.1126/sc…
Vaccines should be offered more broadly to populations, uptake should be optimized

We also need variant-proof vaccines and vaccines that induce strong mucosal immunity to block infection and transmission

We must broaden the pipeline of antivirals

science.org/doi/10.1126/sc…
Governments and funding agencies should support a comprehensive portfolio of research in infection-associated chronic illnesses

Although SARS-CoV-2 can cause chronic disease, it is not alone. Influenza virus, Epstein-Barr virus, Ebola virus, polio virus, and many others also have long-term health effects.

Myalgic encephalomyelitis/chronic fatigue syndrome is also triggered by infection.

Research in this area has been disproportionately underfunded relative to the burden of long-term disability and disease caused by infections.

science.org/doi/10.1126/sc…
The world has already paid an extraordinarily heavy price for the biggest pandemic of the 21st century so far

In this crisis lies an urgent need to address the challenge of Long Covid

The world must rise to the occasion

Failure must not be an option!

science.org/doi/10.1126/sc…
Thanks to my co-author @EricTopol for working with me on this piece

And thank you @AldertonBiol and your team for all your effort handling this #SciencePerspective

science.org/doi/10.1126/sc…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Ziyad Al-Aly, MD

Ziyad Al-Aly, MD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @zalaly

Dec 24, 2023
3 key messages from our recent paper in @TheLancetInfDis

1. Covid is worse than flu

Covid remains a much more serious threat to human health than the flu

thelancet.com/journals/lanin…
2. Comparing the two:

COVID is more multisystemic
Flu is more respiratory

thelancet.com/journals/lanin…
3. Both covid and flu cause more health loss in the long-term than what is evident around the time of the infection

Trivializing these illnesses as inconsequential ignores the large burden of health loss that occurs in the post-acute/chronic/long phase

thelancet.com/journals/lanin…
Read 4 tweets
Dec 16, 2023
Some people objected to use of the term “long flu”

Let me explain

A thread

thelancet.com/journals/lanin…
Lets start with the evidence about health loss

higher in post-acute flu than acute flu

higher in post-acute covid (long covid) than acute covid

In both acute and post-acute phases, burden of health loss was higher in covid than flu

thelancet.com/journals/lanin…
For me, a big revelation from the study was:

the realization that when you measure it, the burden of health loss is higher in post-acute (long) phase of illness than acute phase of illness

I knew this about covid
I did not know this about flu
Read 10 tweets
Dec 14, 2023
📣 New from my team in @TheLancetInfDis

Long-term outcomes of people hospitalized for COVID-19 vs seasonal influenza

A 🧵

thelancet.com/journals/lanin…
The study included:

81,280 individuals hospitalized for SARS-CoV-2
&
10,985 individuals hospitalized for seasonal influenza

We followed them for 1.5 years to characterize the risks of death, health care utilization & 94 health outcomes

thelancet.com/journals/lanin…
Covid had higher risk of death, healthcare utilization and sequelae in most organ systems than flu

This was evident in pre-delta, delta, and omicron; and also evident in vaccinated and unvaccinated individuals.

thelancet.com/journals/lanin…

Image
Image
Read 9 tweets
Aug 21, 2023
1/ 📣 New from my team in @NatureMedicine

In a study of 6 million people, we examined risk trajectories of 80 components of Long Covid over 2 years post-infection

📌 Risks remained elevated for many Long Covid conditions even 2 years infection

A 🧵

nature.com/articles/s4159…
2/ The study included:

138,818 individuals with SARS-CoV-2
&
5,985,227 non-infected controls

We followed them for 2 years to characterize the risk trajectories of death, hospitalization and 80 components of Long Covid

nature.com/articles/s4159…
3/ In people who were not hospitalized during the acute phase of COVID (the majority)

risk of death remained elevated up to 6 months

risk of hospitalization remained elevated up to 19 months

risks remained elevated for 31% of sequelae during the 2-year

nature.com/articles/s4159…
Image
Read 22 tweets
May 10, 2023
My piece in @TheLancetInfDis

Reflections on Long Covid prevention: progress and challenges

A thread

thelancet.com/journals/lanin…
LongCovid does not only affect patients and their life expectancy, but also societal wellbeing and economic indicators (labour participation and economic productivity).

Preventing long COVID should be a public and a global health priority.

thelancet.com/journals/lanin…
All evidence points in the same direction—SARS-CoV-2 antivirals might be important tools for prevention of Long Covid

Paxlovid reduced the risk by 26%

Molnupiravir reduced the risk by 14%

Ensitrelvir may also reduce the risk

thelancet.com/journals/lanin…
Read 12 tweets
Apr 22, 2023
Here is a new thread on our latest study without the full C word - to avoid suppression by the algo

C=kovd

Is C still deadlier than the flu in 2023?

The short answer is yes

New from our team in @JAMA_current

By @Biostayan, Taeyoung Choi and @zalaly

jamanetwork.com/journals/jama/…
In this study of 11,399 people

8996 hospitalized for C & 2403 hospitalized for flu

5.9% died in the C group vs 3.7% died in the flu group

That is a difference of 2.23% deaths

This translates into 60% higher risk of death in C vs flu

jamanetwork.com/journals/jama/…
The 60% higher risk of death in people hospitalized for C vs flu should be interpreted in the context of 2-3 times more hospitalization for C than hospitalization for flu

This compounds the rates of death due to C vs flu

jamanetwork.com/journals/jama/…
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(